Table 5.

Mean myo-inositol concentration (mmol/L) over time

ROI	Group	Visit 1	Visit 3	Visit 5	Visit 7
rACC	Pregabalin	2.95 (± 1.74)	1.72 (± 0.83)	2.73 (± 1.55)	1.88 (± 1.10)
	Placebo	2.42 (± 1.59)	2.32 (± 0.83)	2.39 (± 0.79)	2.12 (± 0.86)
DLPFC	Pregabalin	2.26 (± 1.29)	2.17 (± 0.76)	1.91 (± 0.59)	2.13 (± 0.97)
	Placebo	2.21 (± 0.68)	2.21 (± 0.82)	1.92 (± 1.36)	2.06 (± 0.93)
Thalamus left	Pregabalin	2.15 (± 0.76)	2.49 (± 1.01)	2.17 (± 0.82)	2.63 (± 0.82)
	Placebo	2.29 (± 1.18)	2.67 (± 1.14)	2.34 (± 0.97)	2.56 (± 1.01)
Right thalamus	Pregabalin	2.85 (± 0.93)	2.52 (± 1.13)	2.55 (± 0.88)	2.33 (± 0.96)
	Placebo	2.81 (± 1.17)	2.21 (± 0.89)	2.47 (± 1.08)	2.46 (± 0.70)

Data are presented as the mean ± SD